Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page's revision annotation was updated from v3.5.3 to v3.5.4, indicating a newer release of the page. This appears to be a metadata/version update rather than a substantive content or functionality modification.
    Difference
    0.1%
    Check dated 2026-05-18T13:47:35.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page’s application/version label has been updated from Revision v3.5.2 to v3.5.3, indicating a technical release rather than a change to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-27T07:33:11.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T02:27:41.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0 and v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-22T08:50:48.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Page revision indicator updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-07T20:20:30.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2, which appears to be a backend/version label with no visible impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:58:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.